In vivo T-Cell Depletion with Antithymocyte Globulins Improves Overall Survival after Myeloablative Allogeneic Stem Cell Transplantation in Patients with Hematologic Disorders-Reference-Cited by-同舟云学术

In vivo T-Cell Depletion with Antithymocyte Globulins Improves Overall Survival after Myeloablative Allogeneic Stem Cell Transplantation in Patients with Hematologic Disorders

Published:2013 Issue:3 Volume:129 Page:146-153
ISSN:1421-9662
Container-title:Acta Haematologica
language:en
Short-container-title:Acta Haematol

Author:

Sheng Zhixin,Ma Huanwen,Pang Wenzheng,Niu Shanona,Xu Jingbo

Publisher

S. Karger AG

Subject

Hematology,General Medicine

Reference26 articles.

1. Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

2. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study

3. Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation

4. Nonmalignant late effects after allogeneic stem cell transplantation

5. Chronic graft-versus-host disease

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis;Frontiers in Oncology;2021-08-20

2. Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation;Journal of Cancer Research and Clinical Oncology;2017-01-06

3. Efficacy of antithymocyte globulin for allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis;Leukemia & Lymphoma;2016-12-12

4. The efficacy and safety of rabbit anti-thymocyte globulin vs rabbit anti-T-lymphocyte globulin in peripheral blood stem cell transplantation from unrelated donors;Leukemia & Lymphoma;2015-08-28

5. Outcomes of peripheral blood stem cell transplantation patients from HLA-mismatched unrelated donor with antithymocyte globulin (ATG)-Thymoglobulin versus ATG-Fresenius: a single-center study;Medical Oncology;2015-01-15